National Tuberculosis Advisory Committee 2012 Committee Report

Authors

  • Emily Gearside Vaccine Preventable Diseases Surveillance Section, Office of Health Protection, Australian Government Department of Health
  • National Tuberculosis Advisory Committee

DOI:

https://doi.org/10.33321/cdi.2013.37.27

Keywords:

tuberculosis, disease surveillance

Abstract

Disclaimer: The views expressed in this item are those of the individual authors, and do not necessarily represent the views of the Communicable Diseases Intelligence journal or the Australian Centre for Disease Control. While this Policy and Guidelines item was drafted with consideration to the then-available information on the condition(s) addressed within, it may not be complete and may not represent the currently understood best practice for the referenced condition(s). Readers are advised to refer to the most recent guidance on this matter, where such guidance exists and where its authoritativeness can be established. These guidelines do not replace the need for clinical judgment to be exercised for each individual circumstance, nor the necessity for expert advice to be obtained as appropriate.   

 

The National Tuberculosis Advisory Committee (NTAC) was established in 1999 as a subcommittee of Communicable Diseases Network Australia (CDNA). The terms of reference of NTAC are:

  • to provide strategic, expert advice to CDNA on a coordinated national and international approach to Tuberculosis (TB) control; and
  • to develop and review nationally agreed strategic and implementation plans for the control of TB in Australia

This report documents activities undertaken by NTAC in 2012. 

Downloads

Download data is not yet available.

References

National Tuberculosis Advisory Committee. Position statement on interferon- release assays in the detection of latent tuberculosis infection. Commun Dis Intell 2012; 36(1):125-131.

Christina Barry, Justin Waring, Richard Stapledon, Anastasios Konstantinos and the National Tuberculosis Advisory Committee, for the Communicable Diseases Network Australia. Tuberculosis notifications in Australia, 2008 and 2009. Commun Dis Intell 2012; 36(1):82-94.

National Tuberculosis Advisory Committee. The Strategic Plan for Control of Tuberculosis in Australia: 2011–2015 Commun Dis Intell 2012; 36(3):E286-E293.

National Tuberculosis Advisory Committee. The Bacille Calmette Guérin vaccine (BCG): information and recommendations for use in Australia. Commun Dis Intell 2013; 37 (1): E65-E72.

Department of Immigration and Citizenship. PAM3 - Migration Act - Detention Services Manual - Chapter 6 - Detention health - General health screening and management - Tuberculosis Screening and Management in Immigration Detention. LegendCom. 2013: 03/6/2013-17/6/2013; P: 3/6/2013 - 17/6/2013

Downloads

Published

01/06/13

How to Cite

Gearside, Emily, and National Tuberculosis Advisory Committee. 2013. “National Tuberculosis Advisory Committee 2012 Committee Report”. Communicable Diseases Intelligence 37 (June):187-88. https://doi.org/10.33321/cdi.2013.37.27.

Issue

Section

Policy and guidelines

Categories